Time, the final frontier
- PMID: 40126098
- PMCID: PMC12330933
- DOI: 10.1002/1878-0261.70025
Time, the final frontier
Abstract
Cancer's notorious heterogeneity poses significant challenges, as each tumor comprises a unique ecosystem. While single-cell and spatial transcriptomics advancements have transformed our understanding of spatial diversity within tumors, the temporal dimension remains underexplored. Tumors are dynamic entities that continuously evolve and adapt, and relying solely on static snapshots obscures the intricate interplay between cancer cells and their microenvironment. Here, we advocate for integrating temporal dynamics into cancer research, emphasizing a fundamental shift from traditional endpoint experiments to data-driven, continuous approaches. This integration involves, for instance, the development of advanced live imaging techniques, innovative temporal omics methodologies, and novel computational tools.
Keywords: cancer heterogeneity; circadian clock; live‐cell imaging; metastasis; temporal dynamics; temporal omics.
© 2025 The Author(s). Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical